Search Results 1021-1030 of 17115 for monoclonal antibody
... monoclonal antibody-containing therapy. Note: Relapsed disease is defined as disease that has recurred ≥6 months after completion of therapy. Refractory ...
Known severe allergic reactions to TCZ or other monoclonal antibodies;; Active TB infection;; Suspected active bacterial, fungal, viral, or other infection ...
A Study of Hematopoiesis in Patients with Monoclonal ... Monoclonal B Cell Lymphocytosis (MBL) and B ... antibodies) treatment, CPI-naïve hepatocellular ...
... antibody (HCV ... History of anaphylaxis (excluding infusion related reactions) in association with previous anti-CD20 monoclonal antibody administration.
Use of anti-IgE (e.g., omalizumab) or any other monoclonal antibody, in the 6 months prior to randomization. Use of (Beta) β-blockers within 1 day prior to ...
Complement activation after binding of an IgG autoantibody ... monoclonal IgG that neutralises the complement protein C5--in neuromyelitis optica spectrum ...
... monoclonal antibody have been used to treat EE. EE likely represents another example of eosinophil-associated inflammation of epithelia at the interface ...
Receipt of any marketed or investigational biologic products (monoclonal or polyclonal antibody) ... This also applies to patients who previously participated in ...
... antibody therapy within 42 days of registration; patients may have ... Monoclonal antibodies must not have been received for 1 week prior to registration; ...
Dyn2 localizes to the pericentriolar material and centrioles. FR cells were co-stained for endogenous Dyn2 using either the anti-pan-dynamin antibody MC-63 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.